322 related articles for article (PubMed ID: 27450721)
1. Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells.
Pavlopoulou A; Oktay Y; Vougas K; Louka M; Vorgias CE; Georgakilas AG
Cancer Lett; 2016 Oct; 380(2):485-493. PubMed ID: 27450721
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
[TBL] [Abstract][Full Text] [Related]
3. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.
Kakarala M; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2813-20. PubMed ID: 18539959
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression.
Guo L; Zheng P; Fan H; Wang H; Xu W; Zhou W
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935760
[TBL] [Abstract][Full Text] [Related]
5. Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance.
Palomeras S; Ruiz-Martínez S; Puig T
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200262
[TBL] [Abstract][Full Text] [Related]
6. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.
Semenza GL
Clin Sci (Lond); 2015 Dec; 129(12):1037-45. PubMed ID: 26405042
[TBL] [Abstract][Full Text] [Related]
8. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
[TBL] [Abstract][Full Text] [Related]
9. Identification of Potential Breast Cancer Stem Cell Biomarkers in the Secretome Using a Network Interaction Approach Analysis.
Margaret AL; Wanandi SI; Fadilah F; Paramita RI
Asian Pac J Cancer Prev; 2024 May; 25(5):1803-1813. PubMed ID: 38809653
[TBL] [Abstract][Full Text] [Related]
10. Targeting breast cancer stem cells.
Liu S; Wicha MS
J Clin Oncol; 2010 Sep; 28(25):4006-12. PubMed ID: 20498387
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of breast cancer stem cells: potential clinical applications.
Nguyen NP; Almeida FS; Chi A; Nguyen LM; Cohen D; Karlsson U; Vinh-Hung V
Cancer Treat Rev; 2010 Oct; 36(6):485-91. PubMed ID: 20231058
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer stem cells: Multiple capacities in tumor metastasis.
Geng SQ; Alexandrou AT; Li JJ
Cancer Lett; 2014 Jul; 349(1):1-7. PubMed ID: 24727284
[TBL] [Abstract][Full Text] [Related]
14. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
[TBL] [Abstract][Full Text] [Related]
15. Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells.
Ko YS; Jin H; Lee JS; Park SW; Chang KC; Kang KM; Jeong BK; Kim HJ
Oncol Rep; 2018 Dec; 40(6):3752-3762. PubMed ID: 30272295
[TBL] [Abstract][Full Text] [Related]
16. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer stem cells.
Velasco-Velázquez MA; Homsi N; De La Fuente M; Pestell RG
Int J Biochem Cell Biol; 2012 Apr; 44(4):573-7. PubMed ID: 22249027
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
[TBL] [Abstract][Full Text] [Related]
20. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
